Bristol Myers Squibb (BMY) has announced positive results from True North, a pivotal Phase 3 trial evaluating oral Zeposia (ozanimod) as an induction and …
Bluebird bio Inc. (BLUE) said on Monday its partner Bristol Myers Squibb Co.
Yesterday, Merck (NYSE:MRK) reported data from Keytruda in combo with chemotherapy for patients with non-small cell lung cancer (NSCLC). The data was positive …
Bristol-Myers Squibb Co (NYSE:BMY) announced that the European Commission has approved ORENCIA ® (abatacept) intravenous (IV) infusion and subcutaneous (SC) injection, in combination …
Bristol-Myers Squibb (NYSE:BMY) is expected to report earnings on Tuesday, January 27th. The whisper number is $0.
